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Abstract 
 
A major challenge for genomic research is to establish a relationship among sequences, 
structures and function of genes. In addition processing and analyzing this information are of 
prime importance. Basically genes are repositories for protein coding information and proteins in 
turn are responsible for most of the important biological functions in all cells. These in turn gives 
rise to analysis of DNA sequences in proteins, designing of various drugs for genetic diseases. 
 
This thesis deals with the applications of signal processing and soft computing algorithms to the 
field of genomics and proteinomics. Diseases like SARS and Migraine have been modeled using 
these tools and potential druggable compounds have been proposed which are better than the 
previous available drugs. Protein structural classes have been identified more accurately based 
on Genetic Algorithm and Particle Swarm Optimization.  
 
Better and efficient methods like Sliding-DFT and Adaptive AR Modeling were proposed to 
identify Protein coding regions in genes. The proposed methods showed better results as 
compared to existing methods.  
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1.1 BACKGROUND 
Genomic signal processing (GSP) is the engineering discipline that studies the processing of 
genomic signals, by which we mean the measurable events, principally the production of mRNA 
and protein that are carried out by the genome. Based upon current technology, GSP primarily 
deals with extracting information from gene expression measurements. The analysis, processing, 
and use of genomic signals for gaining biological knowledge constitute the domain of GSP. The 
aim of GSP is to integrate the theory and methods of signal processing with the global 
understanding of functional genomics, with special emphasis on genomic regulation. Hence, 
GSP encompasses various methodologies concerning expression profiles: detection, prediction, 
classification, control, and statistical and dynamical modeling of gene networks. GSP is a 
fundamental discipline that brings to genomics the structural model-based analysis and synthesis 
that form the basis of mathematically rigorous engineering. Signals generated by the genome 
must be processed to characterize their regulatory effects and their relationship to changes at 
both the genotypic and phenotypic levels. Application is generally directed towards tissue 
classification and the discovery of signaling pathways. Because transcriptional control is 
accomplished by a complex method that interprets a variety of inputs, the development of 
analytical tools that detect multivariate influences on decision making present in complex genetic 
networks is essential. To carry out such an analysis, one needs appropriate analytical 
methodologies. Perhaps the most salient aspect of GSP is that it is an engineering discipline, 
having strong roots in signals and systems theory. In GSP, the point of departure is that the living 
cell is a system in which many interacting components work together to give rise to execution of 
normal cellular functions, complex behavior, and interaction with the environment, including 
other cells. In such systems, the “whole” is often more than the “sum of its parts,” frequently 
referred to as emergent or complex behavior. The collective behavior of all relevant components 
INTRODUCTION 
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in a cell, such as genes and their products, follows a similar paradigm, but gives rise to much 
richer behavior, that is characteristic of living systems. To gain insight into the behavior of such 
systems, a systems-wide approach must be taken. This requires us to produce a model of the 
components and their interactions and apply mathematical, statistical, or simulation tools to 
understand its behavior, especially as it relates to experimental data. 
 
1.2 RESEARCH OBJECTIVE 
The fundamental research objectives of this thesis are: 
 Time And Cost Effectiveness Of In-Silico Drug Discovery Process 
The following flow chart shows the cost and time involved in a particular drug discovery 
process 
 
Fig 1.1 Cost and Time involved in Drug Discovery 
 
As structures of more and more protein targets become available through crystallography, 
NMR and bioinformatics methods, there is an increasing demand for computational tools that 
can identify and analyze active sites and suggest potential drug molecules that can bind to 
these sites specifically. Also to combat life-threatening diseases such as AIDS, Tuberculosis, 
Malaria etc., a global push is essential. Millions for Viagra and pennies for the diseases of the 
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poor is the current situation of investment in Pharma R&D. Time and cost required for 
designing a new drug are immense and at an unacceptable level. According to some 
estimates it costs about $880 million and 14 years of research to develop a new drug before it 
is introduced in the market intervention of computers at some plausible steps is imperative to 
bring down the cost and time required in the drug discovery process 
 
 Increasing Importance Of  Protein Structure Prediction 
It is a critical challenge to develop automated methods for fast and accurately determining 
the structures of proteins Because, of the increasingly widening gap between the number of 
sequence known proteins and that of structure known proteins in the post-genomic age. The 
knowledge of protein structural class can provide useful information towards the 
determination of protein structure. Thus, it is highly desirable to develop computational 
methods for identifying the structural classes of newly found proteins based on their primary 
sequence. The structural class has become one of the most important features for 
characterizing the overall folding type of a protein and it has played as important role in 
molecular biology, pharmacology, rational drug design and many other applications. 
 
 
 Effective Method of study of genetic material present in DNA  
The genomic information is present in the strands of DNA and represented by nucleotide 
symbols (A, T, C and G).The segments of DNA molecule called gene is responsible for 
protein synthesis and contains code for protein in exon regions within it. When a particular 
instruction becomes active in a cell, the corresponding gene is turned on and the DNA is 
converted to RNA and then to protein by slicing up to exons (protein coding regions of 
gene). Therefore finding coding regions in a DNA strand involves searching of many 
nucleotides which constitute the DNA strand. Thus the DNA transcription and replication 
process can be decoded in various organisms including human beings and virus which will 
help in study of these organisms and will also assert in making effective medicine for 
different diseases.   
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1.3 THESIS CONTRIBUTION 
This section outlines the major contribution of the thesis. The work done in this thesis has been 
divided into three chapters.  
The first chapter includes the drug designing applications of Soft Computing and Signal 
processing. It consists of two parts of work. In the first work, a novel low complexity functional 
link neural network (FLANN) method is proposed to design inhibitors against the SARS virus 
(SARS 3CL protease) through the quantitative structure activity relationship (QSAR) study of 
the known twenty eight druggable compounds. The binding preferences as well as the hydrogen 
bonds contributing to the interaction between ligand and the SARS protein receptor are studied. 
Based on this, eight compounds are found promising and the main structural features shared by 
these are used to design analogues. Among the analogues the best performing eleven ligands are 
retrieved and put forward for QSAR analysis. Simulation study reveals that the proposed 
FLANN based QSAR model outperforms the existing artificial neural network (ANN) based 
approaches. The new model provides results which are in excellent agreement with the 
experimentally obtained values (r
2
=0.9900, q
2
=0.9900, MSE=0.0001). Using the new model the 
biological activities of the eleven modified compounds are predicted and subsequently screened 
via docking techniques. It is observed that three predicted SARS 3CL protease inhibitors are 
highly active and possess better calculated binding energies compared to those provided by 
experimentally known drug candidates.   
In the second work, we analyzed the performance of a real coded “steady-state” genetic 
algorithm (SSGA) using a grid-based methodology in docking 16 migraine protein-ligand 
complexes having known three-dimensional structures. The SSGA was tested for the rigid and 
flexible ligand docking cases. The final complexes were ranked according to their minimum 
binding energies and were better with respect to previously used drugs for migraine. 
 
In the second chapter, a protein is expressed as a vector of 20-dimensional space, in which its 
components are defined by the composition of its 20 amino acids. From these values the 
structural class predictions for each protein are derived. Examples consisting of 204 previously 
classified proteins are taken and then each sequence is normalized with respect to the 20-amino 
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acids by dividing by their lengths. Then the structural classes were predicted using the Genetic 
algorithm (GA) and Particle Swarm Optimization (PSO) approach. This method was compared 
with the previously used Euclidean distance, Hamming distance, AAPCAb (amino acid Principal 
Component Analysis), Logit-boost and Support vector machine(SVM) method for prediction of 
structural class of proteins. In comparison with the existing methods, the new method yields a 
higher accuracy of prediction. 
The third chapter presents two new efficient approaches as based on sliding DFT (SDFT), 
adaptive AR modeling for identification of coding region exploring the period-3 behavior. The 
performance of the new methods is shown to be identical to that obtained by the Fourier 
transform based method. In addition, the proposed method offers substantial computational 
advantage over the conventional methods. Thus in general the four novel methods proposed have 
distinct computational advantage without sacrificing the quality of gene and exon prediction and 
can be applied for rapid medical applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 6 - 
 
 
 
 
2.1 INTRODUCTION 
Drug design and drug discovery are of critical importance in human life. Its success rate depends 
on in depth study and use of both biological and chemical research employing computational 
approaches. In this chapter a novel low complexity functional link neural network (FLANN) 
method is proposed to design inhibitors against the SARS virus (SARS 3CL protease) through 
the quantitative structure activity relationship (QSAR) study of the known twenty eight 
druggable compounds. The binding preferences as well as the hydrogen bonds contributing to the 
interaction between ligand and the SARS protein receptor are studied. Based on this, eight 
compounds are found promising and the main structural features shared by these are used to 
design analogues. Among the analogues the best performing eleven ligands are retrieved and put 
forward for QSAR analysis. Simulation study reveals that the proposed FLANN based QSAR 
model outperforms the existing artificial neural network (ANN) based approaches. The new 
model provides results which are in excellent agreement with the experimentally obtained values 
(r
2
=0.9900, q
2
=0.9900, MSE=0.0001). Using the new model the biological activities of the 
eleven modified compounds are predicted and subsequently screened via docking techniques. It 
is observed that three predicted SARS 3CL protease inhibitors are highly active and possess 
better calculated binding energies compared to those provided by experimentally known drug 
candidates.   
Migraine is basically a neurological disorder. Migraine headache is a severe pain that is typically 
on one side of the head but sometimes on both sides and can occur at any time of day and can 
last a few hours or up to one or two days. Attacks can be very intense, forcing the sufferer to 
IN-SILICO DRUG DESIGN 
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abandon normal daily activities. This chapter gives a comprehensive pathway for lead molecule 
design for migraine focusing on the emerging in silico trends and techniques which includes 
generation of candidate molecules, checking them for their toxicity and human body likeliness, 
docking them with the target and ranking them based on their binding affinities. After literature 
survey of recent journals it has been found that elevated levels of human receptor activity-
modifying protein-1 (hRAMPI) (2YX8.PDB) is one of the major factors contributing to migraine 
attacks. First this protein sequence is taken from PDB. Its missing side chain prediction was 
performed using sqwrl and the energy minimization was done in chimera using AMBER force 
field. Then blind docking was performed with some of the available drugs in autodock and 
Sumatriptan was found to be the best ligand as it had the lowest binding energy. Pharmacophore 
for Sumatritan is analyzed using the ligandscout and its 15 derivatives are drawn with minimized 
energy in PRODRG using the GROMOS 96.1 force field. The derivatives were analyzed for 
drug-likeliness using Lipinski filters and toxicity using ADME/Tox filter. Protein-ligand 
interactions (docking) for all the derivatives with the protein was found out using Autodock 4.0 
and hex 4.0. By the comparative study of the binding energies of all the complexes thus formed, 
three of the best ligands were chosen and were analyzed for active amino acid groups mainly 
involved in ligand –protein interaction using ligandscout 2.0. The amino acid groups ALA70A 
and ASP90A are found to be involved in binding interaction. 
 
2.2 IN-SILICO DRUG TARGET DESIGN AND ITS APPROACH  
2.2.1 DRUG 
A drug, is any chemical substance that, when absorbed into the body of a living organism, alters 
normal bodily function. 
2.2.2 DRUG DESIGN BASED ON BIOINFORMATICS TOOLS  
Drug design is the approach of finding drugs by design, based on their biological targets. 
Typically a drug target is a key molecule involved in a particular metabolic or signaling pathway 
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that is specific to a disease condition or pathology, or to the infectivity or survival of a microbial 
pathogen. Some approaches attempt to stop the functioning of the pathway in the diseased state 
by causing a key molecule to stop functioning. Drugs may be designed that bind to the active 
region and inhibit this key molecule. However these drugs would also have to be designed in 
such a way as not to affect any other important molecules that may be similar in appearance to 
the key molecules. Sequence homologies are often used to identify such risks. Other approaches 
may be to enhance the normal pathway by promoting specific molecules in the normal pathways 
that may have been affected in the diseased state. 
The structure of the drug molecule that can specifically interact with the biomolecules can be 
modeled using computational tools. These tools can allow a drug molecule to be constructed 
within the biomolecule using knowledge of its structure and the nature of its active site. 
Construction of the drug molecule can be made inside out or outside in depending on whether the 
core or the R-groups are chosen first. However many of these approaches are plagued by the 
practical problems of chemical synthesis. Newer approaches have also suggested the use of drug 
molecules that are large and proteinaceous in nature rather than as small molecules. There have 
also been suggestions to make these using mRNA. Gene silencing may also have therapeutical 
applications. The processes of designing a new drug using bioinformatics tools have open a new 
area of research. However, computational techniques assist one in searching drug target and in 
designing drug in silico, but it takes long time and money. In order to design a new drug one 
need to follow the following path.  
 
 Identify Target Disease:     
One needs to know all about the disease and existing or traditional remedies. It is also important 
to look at very similar afflictions and their known treatments. Target identification alone is not 
sufficient in order to achieve a successful treatment of a disease. A real drug needs to be 
developed. This drug must influence the target protein in such a way that it does not interfere with 
normal metabolism. One way to achieve this is to block activity of the protein with a small 
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molecule. Bioinformatics methods have been developed to virtually screen the target for 
compounds that bind and inhibit the protein. Another possibility is to find other proteins that 
regulate the activity of the target by binding and forming a complex.  
 
 Study Interesting Compounds:  
One needs to identify and study the lead compounds that have some activity against a disease. 
These may be only marginally useful and may have severe side effects. These compounds provide 
a starting point for refinement of the chemical structures.  
 
 Detect the Molecular Bases for Disease:  
If it is known that a drug must bind to a particular spot on a particular protein or nucleotide then a 
drug can be tailor made to bind at that site. This is often modeled computationally using any of 
several different techniques. Traditionally, the primary way of determining what compounds 
would be tested computationally was provided by the researchers' understanding of molecular 
interactions. A second method is the brute force testing of large numbers of compounds from a 
database of available structures.  
 
 Rational drug design techniques: 
Unlike the historical method of drug discovery, by trial-and-error testing of chemical substances 
on cultured cells or animals, and matching the apparent effects to treatments, rational drug design 
begins with a knowledge of specific chemical responses in the body or target organism, and 
tailoring combinations of these to fit a treatment profile. Due to the complexity of the drug design 
process two terms of interest are still serendipity and bounded rationality. Those challenges are 
caused by the large chemical space describing potential new drugs without side-effects. 
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A particular example of rational drug design involves the use of three-dimensional information 
about biomolecules obtained from such techniques as x-ray crystallography and NMR 
spectroscopy. This approach to drug discovery is sometimes referred to as structure-based drug 
design. The first unequivocal example of the application of structure-based drug design leading to 
an approved drug is the carbonic anhydrase inhibitor dorzolamide which was approved in 1995. 
Another important case study in rational drug design is imatinib, a tyrosine kinase inhibitor 
designed specifically for the bcr-abl fusion protein that is characteristic for Philadelphia 
chromosome-positive leukemias (chronic myelogenous leukemia and occasionally acute 
lymphocytic leukemia). Imatinib is substantially different from previous drugs for cancer, as most 
agents of chemotherapy simply target rapidly dividing cells, not differentiating between cancer 
cells and other tissues. 
The activity of a drug at its binding site is one part of the design. Another to take into account is 
the molecule's drug likeness, which summarizes the necessary physical properties for effective 
absorption. One way of estimating drug likeness is Lipinski's Rule of Five. 
 
 Refinement of compounds:  
Once you got a number of lead compounds have been found, computational and laboratory 
techniques have been very successful in refining the molecular structures to give a greater drug 
activity and fewer side effects. This is done both in the laboratory and computationally by 
examining the molecular structures to determine which aspects are responsible for both the drug 
activity and the side effects.  
 
 Molecular Docking 
In the field of molecular modeling, docking is a method which predicts the preferred orientation 
of one molecule to a second when bound to each other to form a stable complex. Knowledge of 
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the preferred orientation in turn may be used to predict the strength of association or binding 
affinity between two molecules using scoring functions. The associations between biologically 
relevant molecules such as proteins, nucleic acids, carbohydrates, and lipids play a central role in 
signal transduction. Furthermore, the relative orientation of the two interacting partners may 
affect the type of signal produced (e.g., agonism vs. antagonism).Therefore docking is useful for 
predicting both the strength and type of signal produced. Most popular approach for structure 
based approach. 
 
 Solubility of Molecule:  
One need to check whether the target molecule is water soluble or readily soluble in fatty tissue 
will affect what part of the body it becomes concentrated in. The ability to get a drug to the 
correct part of the body is an important factor in its potency. Ideally there is a continual exchange 
of information between the researchers doing QSAR studies, synthesis and testing. These 
techniques are frequently used and often very successful since they do not rely on knowing the 
biological basis of the disease which can be very difficult to determine.  
 
 Drug Testing:  
Once a drug has been shown to be effective by an initial assay technique, much more testing must 
be done before it can be given to human patients. Animal testing is the primary type of testing at 
this stage. Eventually, the compounds, which are deemed suitable at this stage, are sent on to 
clinical trials. In the clinical trials, additional side effects may be found and human dosages are 
determined.  
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Fig 2.1 Steps in Drug Target Design 
 
 
2.3 SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 
2.3.1 WHAT IS SARS? 
Severe acute respiratory syndrome (SARS) is the first new infectious disease of this millennium 
which is a form of pneumonia .The symptoms are high fever, nonproductive cough, chills, 
myalgia, lymphopenia, and progressing infiltrates in chest radiography. WHO’s report says, that 
it was one of the major epidemic between November 2002 and July 2003 with the mortality rate 
of 9.6%,. Coronaviruses are positive-strand, enveloped RNA viruses that are important 
pathogens of mammals and birds. These groups of viruses cause enteric or respiratory tract 
infections in a variety of animals including humans, livestock and pets. 
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Fig 2.2 SARS coronavirus (SARS-CoV), the causative agent of the syndrome 
 
2.3.2 HOW DID SARS-COV SUDDENLY APPEAR IN HUMANS? 
Past analysis about the origin of the virus says that SARS-CoV genetic sequence with human and 
domestic animal coronaviruses showed a large difference in them. So, it was hypothesized that 
the new virus might have originated from wild animals, particularly Civet Cats. The Animal 
(Civet cat) coronavirus was found to have 99% sequence similarity with a few deletions and 
mutations in them. A review on the recent reports says that SARS-CoV is different from that of 
the Civet cat virus, and the question whether Civet cat would have been the origin of SARS 
Virus, else Civet cat were also infected from other species is unanswered. Therefore, there are no 
data available on the possibility of horizontal transmission between animals, which hinders our 
knowledge to know the relative speed of evolution of different proteins and further indicate the 
expected stability of therapy against development of resistant strains. This fact raises the 
question whether the jump of the virus from an animal to humans was a single accident or may 
frequently occur in future?, So far, Literatures show that SARS-CoV has the ability to not only 
infect humans but also macaque monkeys, domestic cats, and ferrets, But yet the transmission of 
the virus from the domestic cat to man has not been shown. In this respect, coronaviruses are 
known to easily jump to other species.  
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2.3.3 VIRAL REPLICATION 
SARS-CoV 3C-like protease (SARS-CoV 3CLpro), is a receptor, which is a part of the replicase 
polyproteins, cleaves a functional polypeptide and, consequently, leads to the maturation of 
SARS-CoV. Because of its functional importance in the SARS-CoV replication cycle, SARS-
CoV 3CLpro is considered a potential target to develop novel anti-SARS drugs. Although a 
number of non-peptide inhibitors of SARS-CoV 3CLpro, such as bifunctional aryl boronic acids, 
isatin derivatives, polyphenols, etacrynic acid analogues, cinanserin, and other chemically diverse 
small molecules have been identified, only a few of these show potent inhibitory activity. 
2.3.4 SARS-COV-VARIOUS TARGETS FOR DRUGS /VACCINES-(WHAT FEATURES 
OF SARS-COV AND ITS REPLICATION ARE POTENTIAL TARGETS FOR 
DEVELOPMENT OF NEW ANTIVIRAL DRUGS AND VACCINES?) 
Unfortunately, there are no approved antiviral drugs that are
 
highly effective against 
coronaviruses. However, many steps
 
unique to coronavirus replication could be targeted for 
development
 
of antiviral drugs. Coronavirus infection begins
 
with binding of the spike protein 
(S) on the viral envelope
 
to a specific receptor on the cell membrane. Conformational
 
changes are 
induced in S that probably lead to fusion of the
 
viral envelope with the host cell membrane 
.Molecules
 
that block binding to the receptor or inhibit the receptor-induced
 
conformational 
change in S might block SARS-CoV infection. Inhibitors of HIV-1 entry and membrane fusion 
are good models
 
for new drugs that target this first step in coronavirus infection.
   
 
2.4 MIGRAINE 
2.4.1 WHAT IS MIGRAINE? 
Migraine is basically a neurological disorder. The word migraine is French in origin and comes 
from the Greek hemi crania. Literally meaning "half (the) head". Migraine headache is a severe 
pain that is typically on one side of the head but sometimes on both sides and can occur at any 
time of day and can last a few hours or up to one or two days. Attacks can be very intense, 
forcing the sufferer to abandon normal daily activities. It is commonly experienced between the 
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ages of 15 and 55, most of these sufferers have a family history of Migraine and women are 
affected more than men. 
 
2.4.2 TYPES OF MIGRAINE  
 
1) Common migraine  
2) Classic migraine  
3) Ophthalmoplegic migraine 
4) Hemiplegic migraine  
5) Basilar type migraine  
6) Abdominal migraine  
7) Acephalgic migraine  
 
 
 
 
Fig 2.3 Path Physiology of Migraine (As Taken From Kegg Database). 
 
 
 
2.4.3 MIGRAINE TRIGGERS  
 
A migraine trigger is any factor that, on exposure or withdrawal, leads to the development of an 
acute migraine headache. Triggers may be categorized as behavioral, environmental, infectious, 
dietary, chemical, or hormonal. In the medical literature, these factors are known as 'precipitants.' 
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Migraine attacks may be triggered by: Allergic reactions Bright lights, loud noises, and certain 
odors or perfumes Physical or emotional stress ,Changes in sleep patterns ,Smoking or exposure 
to smoke ,Skipping meals ,Dehydration ,Alcohol or caffeine ,Menstrual cycle fluctuations, birth 
control pills ,Tension headaches ,Foods containing tyramine (red wine, aged cheese, smoked 
fish, chicken livers, figs, and some beans), monosodium glutamate or nitrates (preserved meats) 
,Other foods such as chocolate, nuts, peanut butter, avocado, banana, citrus, onions, dairy 
products, and fermented or pickled foods.  
 
 
2.4.4 TARGETS FOR MIGRAINE 
 
The neuropeptide calcitonin gene-related peptide (CGRP) from the trigeminal    ganglion has 
been established in playing a key role in the pathogenesis of migraine. This study provides the 
evidence that the responsiveness of neuronal CGRP receptors is strongly enhanced in vitro and in 
vivo by expression of human receptor activity-modifying protein-1 (hRAMPI), an obligatory 
subunit of the CGRP receptor. It was demonstrated that activation of CGRP receptors on 
cultured trigeminal ganglion neurons increased endogenous CGRP mRNA levels and promoter 
activity. Here it was shown that RAMP1 is functionally rate limiting for CGRP receptor activity 
in the trigeminal ganglion, which raises the possibility that elevated RAMP1 might sensitize 
some individuals to CGRP actions in migraine. This was taken here as the potential drug target 
for migraine. 
 
2.5 QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS (QSAR) 
Quantitative structure-activity relationship (QSAR) is the process by which chemical structure is 
quantitatively correlated with a well defined process, such as biological activity or chemical 
reactivity. Quantitative structure-activity relationship (QSAR) is a ligand based approach, which 
does not use any structural information of the target, but attempts to correlate the biological 
activity of the ligands with structural description. For example, biological activity can be 
expressed quantitatively as in the concentration of a substance required to give a certain 
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biological response. Additionally, when physiochemical properties or structures are expressed by 
numbers, one can form a mathematical relationship, or quantitative structure-activity 
relationship, between the two. The mathematical expression can then be used to predict the 
biological response of other chemical structures. 
QSAR's most general mathematical form is: 
Activity = f (physiochemical properties and/or structural properties)  
            This computational technique should be used to detect the functional group in your 
compound in order to refine your drug. This can be done using QSAR that consists of computing 
every possible number that can describe a molecule then doing an enormous curve fit to find out 
which aspects of the molecule correlate well with the drug activity or side effect severity. This 
information can then be used to suggest new chemical modifications for synthesis and testing.  
 
 
2.6 FUNCTIONAL-LINK ARTIFICIAL NEURAL NETWORK (FLANN) 
Pao originally proposed FLANN and it is a novel single layer ANN structure capable of forming 
arbitrarily complex decision regions by generating nonlinear decision boundaries. Here, the 
initial representation of a pattern is enhanced by using nonlinear function and thus the pattern 
dimension space is increased. The functional link acts on an element of a pattern or entire pattern 
itself by generating a set of linearly independent function and then evaluates these functions with 
the pattern as the argument. Hence separation of the patterns becomes possible in the enhanced 
space. The use of FLANN not only increases the learning rate but also has less computational 
complexity. Pao et al have investigated the learning and generalization characteristics of a 
random vector FLANN and compared with those attainable with MLP structure trained with 
back propagation algorithm by taking few functional approximation problems. A FLANN 
structure is shown in Fig. 2.4.  
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Let X is the input vector of size N×1 which represents N number of elements; the kth element is 
given by 
 
Each element undergoes nonlinear expansion to form M elements such that the resultant matrix 
has the dimension of N×M.  
The functional expansion of the element by power series expansion is carried out using the 
equation  
 
For trigonometric expansion, the expanded elements are 
 
where. I=1,2,…,M/2. The bias input is unity. So total expanded values including the bias 
becomes Q=M+2.  
Let the weight vector is represented as W having Q elements. The output y is given as 
 
In matrix notation the output can be, 
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Fig 2.4 Functional Link Neural Network (FLANN) Structure 
 
Referring to Fig. 2.4 the error signal e(k ) at k
th
  iteration can be computed as  
 
Let ξ(k) denotes the cost function at iteration k and is given by  
 
where P is the number of nodes at the output layer. 
The weight vector can be updated by least mean square (LMS) algorithm, as 
 
Where  (k) is an instantaneous estimate of the gradient of ξ with respect to the weight vector 
W(k) . It is derived as  
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2.7 PRINCIPAL COMPONENT ANALYSIS (PCA) 
Principal Components Analysis (PCA) is a way of identifying patterns in data, and expressing 
the data in such a way as to highlight their similarities and differences. Since patterns in data can 
be hard to find in data of high dimension, where the luxury of graphical representation is not 
available, PCA is a powerful tool for analyzing data. The other main advantage of PCA is that 
once you have found these patterns in the data, and you compress the data, ie. by reducing the 
number of dimensions, without much loss of information. This technique used in image 
compression.  
Method 
Step 1: Get some data 
The data set which needs dimensionality reduction may be treated as a data set, provided all the 
data’s should be independent variables. We have considered variables of about 28 x 969 
dimensions. 
Step 2: Subtract the mean 
For PCA to work properly, one has to subtract the mean from each of the data dimensions. The 
mean subtracted is the average across each dimension. So, all the x values have x’ (the mean of 
the x values of all the data points) subtracted, and all the y values have y’ subtracted from them. 
This produces a data set whose mean is zero 
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Step 3: Calculate the covariance matrix 
covariance is always measured between 2 dimensions. If we have a data set with more than 2 
dimensions, there is more than one covariance measurement that can be calculated. For example, 
from a 3 dimensional data set (dimensions x,y,z ) you could calculate cov(x,y), cov(y,z) and 
cov(z,x). In fact, for an n -dimensional data set, you can calculate [n! / ((n-2)!*2)] different 
covariance values. A useful way to get all the possible covariance values between all the 
different dimensions is to calculate them all and put them in a matrix 
Step 4: Calculate the eigenvectors and eigenvalues of the covariance Matrix 
It is important to notice that these eigenvectors are both unit eigenvectors ie. Their lengths are 
both 1. This is very important for PCA, but luckily, most maths packages, when asked for 
eigenvectors, will give a unit eigenvectors. So what do they mean?, they provide us with 
information about the patterns in the data. The highest eigenvectors goes through the middle of 
the points, like drawing a line of best fit? That eigenvector is showing us how these two data sets 
are related along that line. The second eigenvector gives us the other, less important, pattern in 
the data, that all the points follow the main line, but are off to the side of the main line by some 
amount. So, by this process of taking the eigenvectors of the covariance matrix, we have been 
able to extract lines that characterise the data. The rest of the steps involve transforming the data 
so that it is expressed in terms of them lines. 
Step 5: Choosing components and forming a feature vector 
Here is where the notion of data compression and reduced dimensionality comes into it. On 
looking at the eigenvectors and eigenvalues from the previous section, one can notice that the 
eigenvalues are quite different values. In fact, it turns out that the eigenvector with the highest 
eigenvalue is the principle component of the data set. 
 It is the most significant relationship between the data dimensions. In general, once eigenvectors 
are found from the covariance matrix, the next step is to order them by eigenvalue, highest to 
lowest. This gives you the components in 
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Order of significance. Now, to reduce one can decide to ignore the components that have lesser 
significance. Only some information, may be lost but if the eigenvalues are small. What needs to 
be done now is one need to form a feature vector, which is just a fancy name for a matrix of 
vectors. This is constructed by taking the needed eigenvectors, and forming a matrix with these 
eigenvectors in the columns.  
Step 6: Deriving the new data set 
This, the final step in PCA, and is also the easiest. Once we have chosen the components 
(eigenvectors) that we wish to keep in our data and formed a feature vector, we simply take the 
transpose of the vector and multiply it on the left of the original data set, transposed. 
Final data=Row feature vector x Row data adjust 
|where row feature vector is the matrix with the eigenvectors in the columns transposed so that 
the eigenvectors are now in the rows, with the most significant eigenvector at the top, and  row 
data adjust is the mean-adjusted data transposed, ie. the data items are in each column, with each 
row holding a separate dimension. It will give us the original data solely in terms of the vectors 
we chose. In the case of when the new data set has reduced dimensionality, ie. We have left some 
of the eigenvectors out, the new data is only in terms of the vectors that 
we decided to keep. To show this on our data,  the final transformation can be taken with each of 
the possible feature vectors. the transpose of the result in each case to bring the data back to the 
nice table-like format.  The other transformation we can make is by taking only the eigenvector 
with the largest eigenvalue.  So what have we done here is we have transformed our data so that 
is expressed in terms of the patterns between them, where the patterns are the lines that most 
closely describe the relationships between the data. This is helpful because we have now, the 
values of the data points tell us exactly where (ie. above/below) the trend lines the data point sits.  
 
2.8 STEADY STATE GENETIC ALGORITHM (SSGA) 
In the implemented SSGA the individual chromosome has three genes representing the ligand 
translation, four genes representing the ligand orientation and the other genes representing the 
ligand conformation. The translational genes are the X, Y, Z reference atom coordinates (usually 
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the closest atom to the ligand center of mass), the orientational genes are a quaternion  
constituted by a unit vector and one orientational angle. The conformational genes are the ligand 
dihedral angles (one gene to each dihedral angle). The ligand-protein energy function used is the 
GROMOS96 classical force field implemented in the THOR program of molecular 
mechanics/dynamics. The force field parameters are adjusted to reproduce experimental results 
(e.g., structural and thermodynamic properties) or higher level ab initio quantum calculations. 
The GROMOS force field is given by: 
 
 
where rij is the distance between the atoms i and j; Aij and Bij  are the Lennard-Jones 
parameters; qi and qj are atomic charges and D is a sigmoidal distance-dependent dielectric 
constant. The first term of the equation corresponds to van der Waals interaction and electrostatic 
interaction between the protein and the ligand molecule, and the last two terms correspond to the 
ligand internal energy interaction, which also have one term for van der Waals interaction and 
one term for electrostatic interaction. The ligand-protein docking problem involves millions of 
energy evaluations, and the computational cost of each energy evaluation increases with the 
number of the atoms of the complex ligand-protein which has thousands of atoms. To reduce the 
computational cost, we implemented a grid-based methodology where the protein active site is 
embedded in a 3D rectangular grid and on each point of the grid the electrostatic interaction 
energy and the van der Waals terms for each ligand atom type are pre-computed and stored, 
taking into account all the protein atoms. In this way the protein contribution at a given point is 
obtained by tri-linear interpolation in each grid cell. A random initial population of individuals is 
generated inside the grid. For translational genes, random values between the maximum and 
minimum grid sizes are generated. For flexible docking, we also generated the initial population 
using a Cauchy distribution. The individual translational genes are generated by adding a random 
perturbation (drawn from a Cauchy distribution) to the grid center coordinates. In this way 
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individuals are generated with higher probability near the grid center, while still permitting that 
individuals be generated far from the center. The Cauchy distribution is given by: 
 
 
 
Where α and β are Cauchy distribution parameters. In this work we used α = 0 and β = 0.75. For 
genes  orresponding to angles (dihedrals and/or orientationals), random values ranging from 0° 
to 360° are generated. Finally, for the  genes corresponding to the orientational unit vector, 
random values between -1 and 1 are used. The individuals are evaluated, and then are selected to 
suffer recombination or mutation. A rank-based selection scheme was used. A new individual is 
inserted in the population if its fitness is better than the fitness of the worst individual in the 
population. The algorithm evolves until the maximum number of the energy evaluations is 
reached. The reproduction operators used are classical two-point crossover and non-uniform 
mutation operators. The non-uniform mutation operator, when applied to an individual i at 
generation n generation, mutates a randomly chosen variable ci according to the following: 
 
 
 
where ai and bi are respectively the lower and upper bounds for the variable ci, ґ is randomly 
chosen as 0 or 1, r is randomly chosen in [0,1] and the parameter b set to 5. In the flexible 
docking, initially one randomly decides if a conformational gene will be mutated or not. Then a 
gene in the chosen group (conformational or not) is randomly selected for mutation. In this way, 
the seven translational/ orientational genes have the same probability of being mutated as the 
conformational ones. 
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2.9 QUANTITATIVE STRUCTURE ACTIVITY MODELING (QSAR) 
USING PCA AND FLANN FOR SARS 
 
2.9.1 DATASET 
A Dataset of 28 non-peptide inhibitor molecules collected from the literature are used in this 
paper for study. All the molecules studied have the same parent skeleton. All these compounds 
share similar chemical structure and a core structure of N-phenyl-2-(pyrimidiny-2-ylsulfanyl) 
acetamide has been identified. This core structure is used as a query structure to search for 
analogues. The selected protein and a single ligand (CMK) found to be crystallized with the 
original protein target. The SARS coronavirus protease (1UK4) is collected from Protein Data 
Bank (http://www.rcsb.org). IC50 is the concentration of the compound leading to 50% inhibitory 
effect. The logarithm transformation of this parameter is used as biological end points (log IC50) 
in the QSAR study so as to move the data to a nearly normal distribution. 
 
2.9.2 GENERATION AND SELECTION OF MOLECULAR DESCRIPTORS BY 
PRINCIPAL COMPONENT ANALYSIS (PCA) 
The collected 28 druggable molecules are built and energy minimized using PRODRG software 
and saved as the mol (output) files. The output files are loaded into PreADMET which is a web-
based application for predicting ADME data and building drug-like library using in- silico 
method. It calculates 955 diverse molecular descriptors which include 60 constitutional 
descriptors, 61 electrostatic descriptors, 16 geometrical descriptors, 130 physicochemical 
descriptor, and 688 topological descriptors. The other structural features of the molecules like 
polar surface area, logP and 14 other descriptors are also calculated from ADME-tox server. A 
total no. of 969 descriptors are calculated for each compound. 
To reduce the redundancy existing in the descriptors data matrix the principal component 
analysis technique (PCA) is used where almost three fourth of the total dimension is reduced. 
Further by clustering the remaining one fourth descriptors it is observed that in some clusters, 
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one descriptor shows maximum explained variance. Such descriptors are first chosen. 
Subsequently any one descriptor from the remaining clusters is selected. All the selected twenty 
variables by this process constitute a feature vector of a compound. The same process is repeated 
for all 28 compounds. 
 
2.9.3 QSAR TECHNIQUE 
Quantitative structure-activity relationship (QSAR) is a ligand based approach, which does not 
use any structural information of the target, but attempts to correlate the biological activity of the 
ligands with structural description. Selected 18 drug molecules are classified into a training set 
and rest 10 into a test set. The test set includes compound 4, 7, 8, 11, 12, 14, 15, 18, 21, 23 and 
the remaining is used as a training set. Artificial neural network (ANN) is performed on these 
data, which correlates biological activity with physicochemical descriptors. The refinement of 
model is based on the consideration of statistical parameters such as correlation coefficient (r
2
), 
cross validated correlation coefficient (q
2
) and the mean squared error (MSE).  
 
2.9.4 DOCKING STUDY 
Using Autodoc 4.0 software the overall lowest binding energy output and the predicted binding 
energy (which is the summation of Intermolecular energy and torsional energy) are computed 
and taken as the criterion for ranking. Using this table eight top conformers based on their lowest 
energies are selected and these are further carefully checked according to ligand’s location and 
size. The objective is to find ligands with good steric complimentarity. Furthermore the 
intermolecular hydrogen bonds are also investigated for these top conformers. The main features 
shared by these eight molecules are used to design analogues for Compound 1, Compound 6, and 
Compound 8. Further modifications of the analogues are made by replacing each one’s existing 
amide bond with all possible substituting peptide bonds collected from the literature. These two 
sets of peptide and amide bonds are collected . All the modified compounds are made to pass 
through ADME/tox filters which screen them via simple filtering rules such as molecular weight, 
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polar surface area, logP or number of rotatable bonds. Only 11 out of 123 overall modified 
ligands retrieved after the screening are found to pass ADME/tox filters with improved binding 
efficiency and steric compatibility. 
 
2.10 MODELLING OF PARAMETERS USING DOCKING FOR 
MIGRAINE 
 
2.10.1 TARGET INDENTIFICATION  
 
Human receptor activity-modifying protein-1 (hRAMPI) protein is sufficient for functionality 
of CGRP and is identified as a drug target for migraine. By inhibiting the activity of hRAMPI 
the migraine attacks can be substantially reduced. The structure of human receptor activity-
modifying protein-1 (hRAMPI) is taken from RCSB Protein data bank whose PDB code is 
2yx8.  
 
2.10.2 TARGET VALIDATION  
 
Receptor structure plays a central role in the target based drug design. The crystal structure of 
2yx8 fetched from the PDB site and identification of secondary structure is done through the 
STRIDE WEB INTERFACE (http://webclu.bio.wzw.tum.de/stride) which generates protein 
secondary structure assignment from atomic co-ordinates based on the combined use of 
hydrogen bond energy and statistically derived backbone tensional angle information to identify 
the number of secondary structure helix, sheet and coil. To check whether any side chain is 
missing or not we use SCWL 3.0 software. (SCWRL3.0 is based on graph theory to solve the 
side chain prediction problem.) The missing residues were fixed using Deep View (The Swiss 
PDB Viewer available at (http://us.expasy.org.spdbv/).  
 
2.10.3 ENERGY MINIMIZATION OF TARGET RECEPTOR  
 
Before energy calculations can be performed, it is necessary to correct structural inconsistencies, 
add hydrogen and associated atoms with force field parameters. Minimization routines are 
 - 28 - 
 
provided by MMTK, which is included with Chimera. The Kollman charges were added to each 
atom of the remained promoter The Amber ff99 force field is used for standard residues, and 
Amber Antechamber module (also included with Chimera) is used to assign parameters to 
nonstandard residues.  
 
2.10.4 PREPARATION OF LIGANDS  
 
The compounds are drawn and are energy minimized in Prodrg server (http://davapc1.bioch) 
using the GROMOS 96.1 force field. Since ligands are not peptides, Gasteiger charge was 
assigned and then non-polar hydrogen‟s were merged. 
Docking: The GA-LS (Lamarckian genetic algorithm) was chosen to search for the best 
conformers. During the docking process, the docking parameters were set as Maximum Number 
of GA runs 100, Population size of 150, Maximum number of evaluation 250000, Rate of Gene 
mutation 0.02, and Rate of Crossover 0.8, for each Compound. The parameters were set using 
the software Autodock Tools. The Calculations of Autogrid and Autodock were performed on 
Linux Operating system having. Evaluation of modified ligands by a flexible docking procedure 
followed by the Screening of ADME/Tox filters. 
At the end of the docking run, it outputs a result which is the lowest energy conformation of the 
ligands, it found during that run. This conformation is a combination of translation, quaternion 
and Torsional angles and is characterized by intermolecular energy, internal energy and 
Torsional energy. The first two of these combined give the „Docking energy‟ while the first and 
third give „Binding energy‟ .Autodock 4.0 also breaks down the total energy into Vander walls 
(vdW) energy and an electrostatic energy for each atom. We used the overall lowest binding 
energy output by Autodock 4.0 and the Predicted binding energy, as the criterion for ranking. 
Therefore after ranking the 3 top conformers according to their lowest energies, the Ligands 
were further carefully checked according to the factor such as ligands location, size of the 
Ligand; to yield ligands with good steric complementarily. Furthermore they were also 
investigated for the 3 top conformers. The main features shared by these 3 top conformers were 
study with help of LigndScout2.0 .and 16 derivatives were design on (basis of the important 
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pharmacophores of three top conformer) PRODRG using the GROMOS 96.1 forcefield .All the 
16 derivatives are passed through ADME/Tox Filter and also ligands are passing through 
Lipinski filter to check whether ligands satisfy the 5 Lipinski rules using. The derivatives are 
docked to the receptor using autodock4.0 tools, best 4 ligand are taken into consideration. The 
important pharmacophores and critical amino acids which are common in all four ligand protein 
complex are predicted using LigndScout2.0. 
 
2.11     SIMULATION RESULTS FOR QSAR STUDY  
 
Table 2.1 Statistical measurement of the model using ANN and FLANN method 
 
 
 
 
 
 
 
 
 
Table 2.2 Binding free Energies for the 28 molecules (Unmodified Compounds) 
Sl. No Compounds Lowest Binding Energies    
(Kcal/mol) 
Binding energies (Torsional 
+Intermolecular) (kcal/mol) 
Rank 1 Rank 2 
1 Compound1 -6.65 -7.57 8 1 
2 Compound2 -6.84 -6.6 5 7 
3 Compound3 -6.66 -6.41 7 8 
4 Compound4 -6.56 -6.89 11 4 
5 Compound5 -6.51 -5.9 12 14 
6 Compound6 -7.45 -6.92 2 3 
7 Compound7 -7.00 -6.79 4 5 
Sl. No r2 q2 MSE No. of 
descriptors 
ANN FLANN ANN FLANN ANN FLANN 
1 0.7956 0.7960 0.7955 0.7956 0.0111 0.0110 1 
2 0.9543 0.9620 0.9542 0.9608 0.0036 0.0034 2 
3 0.9738 0.9762 0.9735 0.9758 0.0017 0.0012 3 
4 0.9825 0.9856 0.9821 0.9852 0.0007 0.0005 4 
5 0.9878 0.9900 0.9872 0.9900 0.0003 0.0001 5 
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8 Compound8 -7.66 -7.42 1 2 
9 Compound9 -5.67 -5.57 26 17 
10 Compound10 -7.06 -6.64 3 6 
11 Compound11 -6.23 -5.12 19 21 
12 Compound12 -6.25 -5.07 18 22 
13 Compound13 -5.97 -4.68 22 25 
14 Compound14 -6.47 -4.96 13 24 
15 Compound15 -6.31 -4.55 16 27 
16 Compound16 -6.44 -5.22 14 19 
17 Compound17 -6.71 -6.00 6 12 
18 Compound18 -6.61 -5.87 9 15 
19 Compound19 -5.9 -5.86 25 16 
20 Compound20 -6.13 -6.08 20 13 
21 Compound21 -4.45 -3.92 28 28 
22 Compound22 -6.4 -6.13 15 11 
23 Compound23 -5.94 -5.40 24 18 
24 Compound24 -6.29 -6.23 17 10 
25 Compound25 -6.59 -6.26 10 9 
26 Compound26 -5.96 -4.68 23 26 
27 Compound27 -5.24 -5.02 27 23 
28 Compound28 -6.09 -5.16 21 20 
 
Table 2.3 Peptide bonds substituents substituted over amide bonds of non-peptide ligands 
S. No Amide bonds of non-peptide ligands (R1-CO-NR2-
R3) 
Various groups substituting peptide bonds 
1 R1-CO-NH-R3 R1-CH2-CH2-R2 
2 R1-CO-NH-R3 R1-CO-O-R2 
3 R1-CO-NH-R3 R1-CHF-S-R2 
4 R1-CO-NH-R3 R1-CF2-NH-R2 
5 R1-CO-NH-R3 R1-CO-CF2-R2 
6 R1-CO-NH-R3 R1-CO-CF2-CO-R2 
7 R1-CO-NH-R3 R1-NH-CH(CF3)-R2 
8 R1-CO-NH-R3 R1-NH-R2 
9 R1-CO-NH-R3 R1-O-R2 
10 R1-CO-NH-R3 R1-NH-N=CH-CO-R2 
11 R1-CO-NH-R3 R1-CO-CO-NH-R2 
12 R1-CO-NH-R3 R1-CH2-NH-R2 
13 R1-CO-NH-R3 R1-CH(OH)-CH2-NH-R2 
14 R1-CO-NH-R3 R1-C(OH)=CH-R2 
15 R1-CO-NH-R3 R1-CH(OH)-CH(OH)-R2 
16 R1-CO-NH-R3 R1-CH(OH)-CH2-R2 
17 R1-CO-NH-R3 R1-CH=CH-R2 
18 R1-CO-NH-R3 R1-CMe=CMe-R2 
19 R1-CO-NH-R3 R1-CH=C(Pro) 
20 R1-CO-NH-R3 R1-C(CF3)=CH-R2 
21 R1-CO-NH-R3 R1-C(CH3)=CH-R2 
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Table 2.4 Observed and the predicted (FLANN) values of logIc50 for the (training + test) set of the 28 
derivatives 
Sl. No Actual logIC50 Predicted logIC50  
(ANN) 
Residual Error 
1 0.477121 0.4908 -0.01368 
2 1 1.0089 -0.0089 
3 1.04139 1.0491 -0.00771 
4 1.07918 1.0908 -0.01162 
5 1.14613 1.1529 -0.00677 
6 1.17609 1.1829 -0.00681 
7 1.17609 1.1826 -0.00651 
8 1.17609 1.1787 -0.00261 
9 1.47712 1.4796 -0.00248 
10 1.60206 1.6035 -0.00144 
11 1.60206 1.6035 -0.00144 
12 1.65321 1.6512 0.00201 
13 1.77815 1.7796 -0.00145 
14 1.77815 1.7733 0.00485 
15 2 1.9968 0.0032 
16 2.30103 2.298 0.00303 
17 2.30103 2.2962 0.00483 
18 2.30103 2.2989 0.00213 
19 2.30103 2.2974 0.00363 
20 2.30103 2.2983 0.00273 
21 2.39794 2.3928 0.00514 
22 2.47712 2.4693 0.00782 
23 2.47712 2.4726 0.00452 
24 2.47712 2.4738 0.00332 
25 2.54407 2.541 0.00307 
26 2.60206 2.5977 0.00436 
27 2.69897 2.6955 0.00347 
28 3 2.9883 0.0117 
 
Table 2.5 Calculated Biological Activity values for the 11 modified ligands 
S. No Modified Compound Lowest Binding Energy     (Kcal/mol) Predicted Log IC50 (ANN) 
1 C1_Ana1_CD_11 -8.00 2.6743 
2 C1_Ana3_CD_18 -8.85 2.4517 
3 C1_Ana3_CD_19 -8.77 2.8433 
4 C8_Ana5_CD_19 -8.86 2.2656 
5 C8_Ana3_CD_14 -8.06 2.8484 
6 C8_Ana3_CD_18 -8.19 2.9301 
7 C8_Ana3_CD_19 -8.62 0.4789 
8 C6_Ana3_CD_11 -8.15 2.7054 
9 C6_Ana3_CD_13 -8.09 0.2906 
10 C6_Ana3_CD_18 -8.44 2.8777 
11 C6_Ana3_CD_19 -9.24 0.1880 
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                    Fig 2.5 the predicted vs. actual activities of training (18) sets 
 
 
 
 
 
 
 
 
 
                    
                       Fig 2.6 the predicted vs. actual activities of test (10) sets 
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2.12 INFERENCES DRAWN FROM QSAR STUDY AND PREDICTING 
POTENTIAL DRUG MOLECULES FOR SARS Co-3CL VIRUS 
The docking results are ranked according to the ascent of the docking energies of the 100 
conformers for each of the ligands. A comparison of the results between rank 1 and rank 2 
suggests that some large sized ligands suffer from more loss of torsional freedom upon binding. 
The top eight compounds are selected based on the comparison of scoring function, which 
predicts the ranking of different ligands in approximate order of ligand size and order of affinity.  
 
From observing the hydrogen bonds formed between compounds 1, 2, 3, 4, 6, 7, 8, 10 (having 
lowest binding energy) and 3CL Protease respectively, it reveals that Asn142 occurs for four 
times, Cys145 for twelve times, His41 for three times, Gly143 occurs for sixteen times, His163 
occurs for two times and Glu166 occurs for six times. From the frequency of the residues 
occurrence in the formation of hydrogen bonding, His41 and Cys145 plays important role, this 
may be due to the carbonyl group of the amide bond and the nitrogen present in the centered 
benzene ring. The other residues like Asn142, Gly143, His163 and Glu166 also take part in the 
hydrogen bonding with relatively high frequency. This information is helpful for our drug design 
in which the potential drug should interact well with these residues, especially with His41 and 
Cys145. His 41 and Cys145 is of great concern in anti-SARS drug design because it is believed 
to be the Catalytic dyad. Therefore we designed analogues for the first three compounds (1, 6 
and 8) keeping the amide bond and the center benzene ring locked such as its catalytic function 
is depressed. For each of the best performing analogues, residue His41 interacting with  the 
carbonyl group of the amide bond whose frequency  of occurrence observed only three times is 
replaced by groups of various possibilities of substituting peptide bonds shown in Table 3. This 
is done with the aim to increase the overall interaction in the form of total binding free energy. 
This docking study results 11 modified better ligands out of 123 overall ones, which are also 
passed the ADME-tox filters with improved binding efficiency and steric complementarity. The 
11 modified compounds found to have improved binding efficiency is screened through the 
model equation with the aim to identify the unique characteristic of compounds and to build the 
relationship between the structure and biological activity. Table 5 reports the calculated 
 - 34 - 
 
biological activity values for the 11 modified ligands. It is found that the C6_Ana3_CD_19 with 
lowest binding energy (-9.24) had a very high biological activity of (0.1880), followed by 
C6_Ana3_CD_13 (0.2906) and C8_Ana3_CD_19 (0.4789) respectively. The above result clearly 
says that C6_Ana3_CD_19, C6_Ana3_CD_13 and C8_Ana3_CD_19 may be considered as 
potential drugs to treat SARS and further wet lab studies are recommended. 
 
2.13     SIMULATION RESULTS FOR DOCKING STUDY USING SSGA 
 
During the docking process, the docking parameters were set as the following for each 
Compound. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.6 Comparisons Of Experimental Binding Affinities And Docking Scores Using Autodock4. 
 
COMPOUNDS  LOWEST BINDING 
ENERGY  
CALCULATED Pki conc  RANK  
Compound1  -5.58  80.62μM  RANK14  
Compound2  -5.75  61.3μM  RANK7  
Compound3  -5.31  127.47μM  RANK16  
Compound4  -5.57  82.31μM  RANK15  
Compound5  -5.7  66.87μM  RANK10  
Compound6  -5.82  54.41μM  RANK5  
Compound7  -5.74  62.01μM  RANK8  
Compound8 -5.75  60.65μM  RANK6  
Compound9  -6.51  16.88μM  RANK2  
Compound10  -6.16  30.62μM  RANK3  
Compound11  -5.62  76.47μM  RANK13  
Compound12  -6.07  35.82μM  RANK4  
Compound13  -6.6  14.45μM  RANK1  
Compound14  -5.68  68.79μM  RANK11  
Compound15  -5.66  71.24μM  RANK12  
Compound16  -5.73  62.58μM  RANK9  
Maximum Number of GA runs 100 
Population size of 150 
Maximum number of evaluation 
250000 
Rate of Gene mutation 0.02 
Rate of Crossover 0.8 
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Fig 2.7 Interaction between hRAMPI receptor and best ligands 
 
2.14 INFERENCES DRAWN FROM DOCKING STUDY USING SSGA 
 
The docking results are ranked according to the ascent of the docking energies of the 100 
conformers for each of the ligands. Ranking the energy results according to the Binding Energy 
which Included the Intermolecular Energy and the Torsional terms, It was found that most of the 
Ligands Interacted quite well with the receptor in the pocket. A Comparison of the results 
between Rank1, Rank2, Rank3 and Rank4 suggests that some large sized Ligands suffer from 
more loss of Torsional freedom upon binding. The top three compounds was selected based on 
the comparison of Scoring function, which predicts the ranking of different ligands in 
approximate order of Ligand size, order of affinity, allows selectivity and was helpful in setting 
up the priorities. It shows that compound no-13, 9, 10, 12 has lowest binding energy and the 
compound were Also checked for their conformations from the output dlg file of a docking run, 
found at the compounds were also checked for their conformation from the output dlg file of a 
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docking run, and are sorted out according to their RMSD values. We found a cluster of 2 
conformations in compound13, a cluster of 8 conformations in Compound 9, a cluster of 19 
conformations in Compound10, a cluster of 35 conformations in compound12 all observed with 
a RMSD tolerance set to 2.0.The recurrence of the identical conformations of one ligand means 
that fits well to the pockets and is likely to be a good inhibitor candidate. 
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3.1 INTRODUCTION 
In the post genomic era the study of sequence to structure relationship and functional annotation 
plays an important role in molecular biology. In this context protein fold prediction is one of the 
major tasks in protein science. The functions of protein are relevant to its 3D structure. The 
function of protein can be efficiently determined by the sequence analysis and structure analysis. 
The knowledge of protein structural class can provide useful information towards the 
determination of protein structure. The exponential growth of the newly discovered protein 
sequences by different scientific community made a large gap between the number of sequence-
known proteins and the number of structure-known proteins. Hence there is a critical challenge 
to develop automated methods for fast and accurately determining the structures of proteins in 
order to reduce the gap. Therefore the development of computational methods for identifying the 
structural classes of newly found proteins based on their primary sequence is essential. The 
structural class has become one of the most important features for characterizing the overall 
folding type of a protein and it has played as important role in molecular biology, pharmacology, 
rational drug design and many other applications. 
 
The concept of protein structural classes was proposed by Levitt & Chothia on a visual 
inspection of polypeptide chain topologies in a dataset of 31 globular proteins. He proposed ten 
structural classes, four principal and six small classes of protein structure. But the biological 
community follows the first four principal classes and these are: all α, all β, α+β and α/β classes. 
The all-α and all-β classes represent structures that consist of mainly α-helices and β-strands, 
respectively. The α/β and α+β classes contain both α-helices and β-strands which are mainly 
interspersed and segregated.  α class: Proteins of this class contain more than 45% α-helices and 
PROTEIN STRUCTURAL 
CLASS PREDICTION 
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less than 5% β-strands. β class: Proteins of this class contain less than 5% α-helices and more 
than 45% β-strands. α+β class: Proteins of this class contain more than 30% a-helices and more 
than 20% P-strands with dominantly anti-parallel β-strands. α/β class: Proteins of this class 
contain more than 30% a-helices and more than 20% β-strands with dominantly parallel β-
strands. These class definitions have been well accepted and are still in common use by many 
researchers. 
 
 
The development of predicting protein structural classes from the primary sequence are mainly 
focused on the two aspects. First is the effective representation of the protein sequence and then 
the development of the powerful classification algorithms to efficiently predict the class. Many 
in-silico structural class prediction algorithms and methods have developed in few decades.  
Many amino acid indices and feature s are used for the assignment of the protein sequence. 
Nishikawa et al. first indicated that the protein structural classes are strongly related to the 
Amino Acid composition (AA). Auto-correlation functions based on non-bonded residue energy, 
polypeptide composition, pseudo AA composition and complexity measure factor have been 
used by many researchers. Several classification methods are also proposed such as distance 
classifier, component coupled methods, Principal component analysis and support vector 
machine. Although promising results have been achieved, the representation of protein with AA 
lacks sequence-order information and sequence-length information. In this chapter we have 
proposed a novel optimization approach for the prediction of protein structural class using 
Genetic Algorithm (GA) and Particle swarm Optimization (PSO). We have used the modified 
amino acid composition vector proposed by Fei Gu et al. which contains the sequence length 
information.  
 
3.2 PROTEIN STRUCTURAL CLASS 
3.2.1 PROTEIN 
Proteins are an important class of biological macromolecules present in all biological organisms, 
made up of such elements as carbon, hydrogen,  nitrogen, oxygen, and  sulphur. All proteins 
are polymers of amino acids. The polymers, also known as polypeptides consist of a sequence of 
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20 different L-α-amino acids, also referred to as residues. For chains under 40 residues the 
term peptide is frequently used instead of protein. To be able to perform their biological 
function, proteins fold into one, or more, specific spatial conformations, driven by a number of 
non covalent interactions such as hydrogen bonding, ionic interactions, Vander Waals 
forces and hydrophobic packing. In order to understand the functions of proteins at a molecular 
level, it is often necessary to determine the three dimensional structure of proteins. This is the 
topic of the scientific field of structural biology, that employs techniques such as X-ray 
crystallography  or  NMR spectroscopy, to determine the structure of proteins. 
A number of residues are necessary to perform a particular biochemical function, and around 40-
50 residues appears to be the lower limit for a functional domain size. Protein sizes range from 
this lower limit to several thousand residues in multi-functional or structural proteins. However, 
the current estimate for the average protein length is around 300 residues. Very large aggregates 
can be formed from protein subunits, for example many thousand actin molecules assemble into 
a microfilament. 
3.2.2 LEVELS OF PROTEIN STRUCTURE 
 
Biochemistry refers to four distinct aspects of a protein's structure: 
 Primary structure - the amino acid sequence of the peptide chains. 
 Secondary structure - highly regular sub-structures (alpha helix and strands of beta 
sheet) which are locally defined, meaning that there can be many different secondary 
motifs present in one single protein molecule. 
 Tertiary structure - three-dimensional structure of a single protein molecule; a spatial 
arrangement of the secondary structures. It also describes the completely folded and 
compacted polypeptide chain. 
 Quaternary structure - complex of several protein molecules or polypeptide chains, 
usually called protein subunits in this context, which function as part of the larger 
assembly or protein complex. 
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Fig 3.1 Four Types Of Protein Structure 
 
3.2.3 STRUCTURAL CLASSES 
A protein (domain) is usually classified into one of the following four structural classes: all-α, 
all-β, α/β, and α + β. Structural class categorizes various proteins into groups that share 
similarities in the local folding patterns. The all-α and all-β classes represent structures that 
consist of mainly α-helices and β-strands, respectively.  
The α/β class represents those proteins containing both α- helices and β- strands that are largely 
interspersed in forming mainly parallel β- sheets, while the α+β class represents those containing 
also both α- helices and β- strands but they are largely segregated in forming mainly antiparallel 
β- sheets. Prediction of structural classes is based on identifying these folding patterns based on 
thousands of already categorized proteins, and applying these patterns to unknown structures but 
known amino acid sequences. The structural class of a protein presents an intuitive description of 
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its overall folding and the restrictions of the structural class have a high impact on its secondary 
and tertiary structure prediction. Therefore, the prediction of the four principal protein structural 
classes is the foundation in the field of protein analysis. 
 
 
3.2.4 AMINO ACIDS IN PROTEINS 
An amino acid is a molecule containing both amine and carboxyl functional groups. These 
molecules are particularly important in biochemistry, where this term refers to alpha-amino acids 
with the general formula H2NCHRCOOH, where R is an organic substituent. In the alpha amino 
acids, the amino and carboxylate groups are attached to the same carbon, which is called the α–
carbon. The various alpha amino acids differ in which side chain (R group) is attached to their 
alpha carbon. They can vary in size from just a hydrogen atom in glycine through a methyl 
group in alanine to a large heterocyclic group in tryptophan. 
Amino acids are critical to life, and have a variety of roles in metabolism. One particularly 
important function is as the building blocks of proteins, which are linear chains of amino acids. 
Amino acids are also important in many other biological molecules, such as forming parts 
of coenzymes, as in S-adenosylmethionine, or as precursors for the biosynthesis of molecules 
such as heme. Due to this central role in biochemistry, amino acids are very important 
in nutrition. 
  
Fig 3.2 Basic Structure of an Amino Acid  
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Table 3.1 Twenty Different Amino Acids 
 
 
 
3.3 LITERATURE REVIEWS OF COMPUTATIONAL TOOLS USED TO 
PREDICT PROTEIN STRUCTURAL CLASS 
 
3.3.1 EUCLIDEAN DISTANCE 
According to this algorithm, the potential function of a query protein in the 20-D composition 
space is given by 
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where k(0) is a force constant, which is trivial here and can be left out in calculation because it is 
the same for all the structural classes. As we know from a basic law in physics, a system will 
become the most stable when it is in a state with the lowest potential, or strictly speaking, the 
lowest free energy. Accordingly, if U(0)(X, X
α
) is the smallest among U(0)(X, X
ξ
) (ξ=α, β, α/β 
and α+β), the protein X will fold into the all-a structural class; if U(0)(X, Xβ) the smallest, then it 
will fold into the all-b class; and so forth. Therefore, the recognition rule should be formulated as 
 
 
where, can be a, b, a/b, or a 1b, and the operator Min means taking the least one among those in 
the parentheses, and the superscript , represents the very structural class which the protein X 
belongs to. If there is a tie case, is not uniquely determined, but that rarely occurs. As we can see, 
after leaving out the constant k(0), U0(X, X
l
,) actually represents the squared Euclidean distance 
between X and X
ξ 
 as used by Nakashima et al. for recognizing the protein structural class.  
 
 
3.3.2 HAMMING DISTANCE METHOD 
 Forming of nucleation. A nucleation can be predicted when 4 of 6 sequential residues in 
certain segment tend to form helix (the helix former), and this number is 3 of 5 for strand. 
 The nucleation regions are extended along both directions of the sequence until the 
average 4-peptides propensities drops below 1. 
 If any extended segment with average propensities Pα  > 1.03(helical propensities larger 
than 1.03 are strong alpha former and alpha former) and Pα  > Pβ  (subscript α means 
helical propensities while β corresponds to strand propensities), it can be predicted as 
helix. And the condition changes to Pβ  > 1.05 (strand propensities larger than 1.05 are 
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strong strand former and strand former) and Pβ  > Pα  for strand. If both helix and 
strand are predicted in certain region (overlapped region), the secondary structure 
conformation with higher average propensities is predicted. 
 
3.3.3 PRINCIPAL COMPONENT ANALYSIS (PCA) 
PCA does not use the conventional amino acid components as the bases for the 20D composition 
space, but instead reorganizes them to a set of orthogonal and normalized base functions through 
a process of linear combination. 
 
In the PCA approach the 20-dimensional amino acid composition space is reduced to an 
orthogonal space with fewer dimensions, and the original base functions are converted into a set 
of orthogonal and normalized base functions. The advantage of such an approach is that it can 
minimize the random errors and redundant information in protein dataset through a principal 
component selection, remarkably improving the success rates in predicting protein structural 
classes. 
 
The essence of the idea of PCA is to optimize the dimensions of the original data matrix so as to 
exclude the overstaffed information and the random errors. To realize this, let us define the data 
matrix Dτ from the composition matrix Mτ as follows: 
 
 
Where T is the transpose operator and 
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The data matrix Dτ is symmetrical and positive definite matrices. According to linear algebra, it 
must have 20 non-negative Eigen values, which can be obtained by solving the following 
equation: 
 
 
where λi  is the jth Eigen value for the τth subset 
The PCA approach uses less orthogonal variables to represent the original data as described 
below. The number of principal eigenvectors is defined by setting a threshold value according to 
the following equation 
 
 
 
The query protein X is predicted belonging to the subset with which it has the largest predictive 
value. In other words, suppose 
 
 
Where the operator means taking the maximum for those in the brackets, then we have X є Sm, 
meaning the query protein belongs to the mth subset. 
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3.3.4 LOGITBOOST 
 
 
 
 
 
The working dataset was taken from Chou (1999) that contains 204 protein chains, of which 52 
are all-α proteins, 61 all-β proteins, 45 α/β proteins and 46 α+β proteins. Their average sequence 
similarity scores are 21% for all- α, 30% for all- β, 15% for α/β and 14% for α+β. Therefore, the 
majority of the proteins are not similar to each other in this dataset. In this study the protein 
samples are represented by their amino acid compositions, and hence each input of the 
LogitBoost corresponds to a vector or point in a 20-dimensional space. 
 
 
 
3.3.5 SUPPORT VECTOR MACHINE (SVM) 
 
Support vector machine (SVM) is a kind of learning machine based on statistical learning theory. 
first, map the input vectors into one feature space (possible with a higher dimension), either 
linearly or non-linearly, which is relevant  with the selection of the kernel function. Then, within 
the feature space from the first step, seek an optimized linear division, i.e. construct a hyperplane 
which separates two classes (this can be extended to multi-class). SVM training always seeks a 
global optimized solution and avoids over-fitting, so it has the ability to deal with a large number 
of features. SVMs have been used in a range of problems including drug design, image 
recognition and text classification. In this method, Vapnik‟s support vector machine is applied 
for predicting the structural classes of proteins.  
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Suppose we are given a set of samples, i.e. a series of input vectors XiєRd (i=1, ..., N) with 
corresponding labels yi_{+1,−1} (i=1, ..., N). 
Here −1 and +1 are used to represent, respectively, the two classes. The goal here is to construct 
one binary classifier or derive one decision function from the available samples, which has small 
probability of misclassifying a future sample. Both the basic linear separable case and the most 
useful linear non-separable case for most real life problems are considered here. For the SVM, 
the width of the Gaussian RBFs is selected as that which minimized an estimate of the VC-
dimension. The parameter C that controls the error-margin trade-off is set at 150. After being 
trained, the hyperplane output by the SVM was obtained. This indicates that the trained model, 
i.e. hyperplane output which is including the important information, has the function to identify 
protein structural classes. 
 
 
 
 
3.4 GENETIC ALGORITHM (GA) 
Genetic algorithm is a part of evolutionary computing, which is a rapidly growing area of 
artificial intelligence. Genetic algorithm is inspired by Darwin's theory of evolution. In this case 
the problems are solved by an evolutionary process resulting in a best (fittest) solution 
(survivor).  
Evolutionary computing was introduced in the 1960s by I. Rechenberg in his work "Evolution 
strategies". His idea was then developed by other researchers. Genetic Algorithm (GAs) was first 
imposed by John Holland and developed by his students and colleagues and are available in the 
book "Adaption in Natural and Artificial Systems" published in 1975. 
 
3.4.1 BASIC PRINCIPLES OF GA  
 
The Algorithm begins with a set of possible solutions called chromosomes which are used to 
assess the cost surface of the problem. The process can be thought of as solution breeding in that 
it creates a new generation of solutions by crossing two chromosomes. The solution variables or 
genes that provide a positive contribution to the population multiply and be passed through each 
subsequent generation until an optimal combination is obtained.  
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The population is updated after each learning cycle through three evolutionary processes: 
selection, crossover and mutation. These create the new generation of solution variables. 
 
Fig 3.3 A GA iteration cycle 
 
The selection function creates a mating pool of parent solution strings based upon the “survival 
of the fittest” criterion. From the mating pool the crossover operator exchanges gene 
information. This essentially crosses the more productive genes within the solution population to 
create an improved, more productive generation. Mutation randomly alters selected genes, which 
helps prevent premature convergence by pulling the population into unexplored areas of the 
solution surface and adds new gene information into the population. 
 
3.4.2 OPERATORS OF GA  
 
As one can see from the iteration cycle of genetic algorithm selection, crossover and mutation 
are the most important parts of the genetic algorithm. The performance is influenced mainly by 
these three operators.  
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 Encoding of a Chromosome  
A chromosome should in some way contain information about solution that it represents. The 
most used way of encoding is a binary string.  
A chromosome then could look like this:  
 
Chromosome 1 : - 1101100100110110 
Chromosome 2 : - 1101111000011110 
Fig 3.4 Chromosome 
Each chromosome is represented by a binary string. Each bit in the string can represent some 
characteristics of the solution. There are many other ways of encoding. The encoding depends 
mainly on the solved problem. For example, one can encode directly integer or real numbers; 
sometimes it is useful to encode some permutations and so on. 
 
 Initial population generation 
The initial population is generated randomly in the range of each parameter. Therefore, at the 
beginning of the separating procedure, N individuals are generated as random binary string. The 
GA starts with a group of chromosomes known as the population. The population has Npop 
chromosomes and is an Npop * Nbits matrix filled with random ones and zeros generated using  
 
Pop =round (rand(Npop, Nbits)); 
 
where the function (Npop, Nbits) generates a Npop * Nbits matrix of uniform random numbers 
between zero and one. The function round rounds the numbers to the closest integer which in this 
case is either 0 or 1. Each row in the pop matrix is a chromosome.  
 
 Evaluation of fitness 
After the initial population generations, the fitness of each individual is determined. Fitness is a 
numeric index to measure the effectiveness of each individuals of the population as a solution, 
which is usually utilized to select members of the population for reproduction.  
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 Selection Operation 
A pair of individuals is selected from the current population for mating using tournament 
selection.  
In this, Selection procedure can be easily adjusted by changing the tournament size. If the 
tournament size is larger, weak individuals have a smaller chance to be selected. 
 
 
 
 
 
Deterministic tournament selection selects the best individual (when p=1) in any tournament. A 
1-way tournament (k=1) selection is equivalent to random selection. The chosen individual can 
be removed from the population that the selection is made from if desired, otherwise individuals 
can be selected more than once for the next generation. 
Tournament selection has several benefits: it is efficient to code, works on parallel architectures 
and allows the selection pressure to be easily adjusted. 
 Crossover  
The crossover operator exchanges gene information between two selected chromosomes, where 
this operation aims to improve the diversity of the solution vectors. The pair of chromosomes, 
taken from the mating pool, becomes the parents of two offspring chromosomes for the new 
generation.  
A binary crossover operation can be either single point or two point crossover. The simplest way 
to do single point crossover is to choose randomly some crossover point and copy everything 
before this point from the first parent and then copy everything after the crossover point from the 
other parent. In Fig.2.10 the sixth crossover position is randomly chosen, where the first position 
Tournament selection pseudo code: 
choose k (the tournament size) individuals from the population at random 
choose the best individual from pool/tournament with probability p 
choose the second best individual with probability p*(1-p) 
choose the third best individual with probability p*((1-p)^2) 
and so on... 
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corresponds to the left side. The bits from the right of the fifth bit are exchanged to produce two 
offspring chromosomes.  
Single point crossover can be illustrated as follows:  
 
 
 
 
Fig 3.5 Single point Crossover 
 
In two point crossover two points are randomly chosen and the bits in between them are 
exchanged. 
 
 
Fig 3.6 Double point Crossover 
 
 Mutation Operation 
Random mutation operator is applied to the newly generated offspring to prevent from premature 
convergence. In this process randomly two parents are chosen and the binary bit positions are 
also selected randomly. Then mutations are done by changing the bit „0‟ to „1‟ in that position or 
vice versa with a probability expressed by, m P, where m P is called mutation probability. Thus a 
new set of offspring‟s are formed as shown below a „0‟ in the second bit changed to „1‟. 
 
11001001 => 10001001 
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After all the above processes the final set of best population are chosen from it which replaces 
the initial population thus continuing the cycle till the best fit population is obtained. 
 
 
3.5 PARTICLE SWARM OPTIMIZATION (PSO) 
 
3.5.1 BASIC CONCEPT OF PSO  
 
The Particle Swarm Optimization (PSO) was developed by Eberhart and Kennedy in 1995 
inspired by swarm intelligence theory such as birds flocking, fish schooling etc. It refers to a 
relatively new family of algorithms where the individuals evolved through generation by 
cooperation and competition among each other. In other evolutionary algorithms the 
evolutionary operators are used to manipulate individuals.  
 
3.5.2 HOW ARE THE VALUES OF ‘X AND Y’ ARE UPDATED IN EVERY 
ITERATION? 
The vector representation for updating the values for x and y is given in Figure 3.7. Let the 
position of the swarms be at „a‟ and „b‟ respectively as shown in the figure. Both are trying to 
reach the position „e‟. Let „a‟ decides to move towards „c‟ and „b‟ decides to move towards„d‟. 
The distance between the position „c‟ and „e‟ is greater than the distance between„d‟ and „e‟. So 
based on the neighbor‟s decision position„d‟ is treated as the common position decided by both 
„a‟ and „b‟. (ie) the position „c‟ is the individual decision taken by „a‟, position „d‟ is the 
individual decision taken by „b‟ and the position „d‟ is the common position decided by both „a‟ 
and „b‟. 
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Fig 3.7 Vector Representation of PSO Algorithm 
 
„a‟ based on the above knowledge, finally decides to move towards the position „g‟ as the linear 
combination of „oa‟ , „ac‟ and „ad‟ . [As „d‟ is the common position decided].The linear 
combination of „oa‟ and scaled „ac‟ (ie) „af‟ is the vector „of‟. The vector „of‟ combined with 
vector „fg‟ (ie) scaled version of „ad‟ to get „og‟ and hence final position decided by „a‟ is „g‟. 
Similarly, „b‟ decides the position „h‟ as the final position. It is the linear combination of „ob‟ 
and „bh‟(ie) scaled version of „bd‟. Note as „d‟ is the common position decided by „a‟ and „b‟, 
the final position is decided by linear combinations of two vectors alone. Thus finally the swarms 
„a‟ and „b‟ moves towards the position „g‟ and „h‟ respectively for reaching the final destination 
position „e‟. The swarm „a‟ and „b‟ randomly select scaling value for linear combination. Note 
that „oa‟ and „ob‟ are scaled with 1 (ie) actual values are used without scaling. Thus the decision 
of the swarm „a‟ to reach „e‟ is decided by its own intuition along with its neighbor‟s intuition. 
Now let us consider three swarms (A,B,C) are trying to reach the particular destination point „D‟. 
A decides A‟, B decides B‟ and C decides C‟ as the next position. Let the distance between the 
B‟ and D is less compared with A‟D and C‟ and hence, B‟ is treated as the global decision point 
to reach the destination faster. Thus the final decision taken by A is to move to the point, which 
is the linear combination of OA, AA‟ and AB‟. Similarly the final decision taken by B is to move 
the point which is the linear combination of OB, BB‟. The final decision taken by C is to move 
the point which is the linear combination of OC, CC‟ and CB‟. 
 
3.5.3 PSO ALGORITHM TO MAXIMIZE THE FUNCTION F (X, Y, Z) 
1. Initialize the values for initial position a, b, c, d, e. 
2. Initialize the next positions decided by the individual swarms as a‟, b‟, c‟, d‟ and e‟. 
- 54 - 
 
3. Global decision regarding the next position is computed as follows. 
Compute f (a‟, b, c, d, e), f (a, b‟, c, d, e), f (a, b, c‟, d, e), f (a, b, c, d‟, e) and f (a, b, c, d, e‟). 
Find minimum among the computed values. If f (a‟,b, c, d, e) is minimum among all, the global 
position decided regarding the next position is a‟. Similarly If f (a, b‟, c, d, e) is minimum among 
all, b‟ is decided as the global position regarding the next position to be shifted and so on. Let the 
selected global position is represented ad „global‟. 
4. Next value for a is computed as the linear combination of „a‟ , (a‟-a) and (global-a) (ie) 
• nexta = a+ C1 * RAND * (a‟ –a) + C2 * RAND * (global –a ) 
• nextb = b+ C1 * RAND * (b‟ –b) + C2 * RAND * (global –b) 
• nextc = c+ C1 * RAND * (c‟ –c) + C2 * RAND * (global –c ) 
• nextd = d+ C1 * RAND * (d‟ –d) + C2 * RAND * (global –d ) 
• nexte = e+ C1 * RAND * (e‟ –e) + C2 * RAND * (global –e ) 
5. Change the current value for a, b, c, d and e as nexta, nextb, nextc, nextd and nexte. 
6. If f (nexta, b, c, d, e) is less than f (a‟, b, c, d, e) then update the value for a‟ as nexta, 
otherwise a‟ is not changed. 
If f (a, nextb, c, d, e) is less than f (a, b‟, c, d, e) then update the value for b‟ as nextb, otherwise 
b‟ is not changed. 
If f (a, b, nextc, d, e) is less than f (a, b, c‟, d, e) then update the value for c‟ as nextc, otherwise 
c‟ is not changed. 
If f (a, b, c, nextd, e) is less than f (a, b, c, d‟, e) then update the value for d‟ as nextd, otherwise 
d‟ is not changed. 
If f (a, b, c, d, nexte) is less than f (a, b, c, d, e‟) then update the value for e‟ as nexte, otherwise 
e‟ is not changed. 
 
7. Repeat the steps 3 to 6 for much iteration to reach the final decision. 
The values for „c1‟,‟c2‟ are decided based on the weightage given to individual decision and 
global decision respectively. 
Let Δa(t) is the change in the value for updating the value for „a‟ in t iteration, then nexta at 
(t+1)th iteration can be computed using the following formula. This is considered as the velocity 
for updating the position of the swarm in every iteration. Where 
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nexta (t+1) = a(t) + Δa(t+1) 
a(t+1) = c1 * rand * (a‟ –a ) + c2 * rand * ( gl obal –a ) + w(t)* Δa(t) 
 
„w ( t )‟ is the weight at tth iteration. The value for „w‟ is adjusted at every iteration as given 
below, where „iter‟ is total number of iteration used. 
 
w(t+1)=w(t)-t*w(t)/(iter) 
 
Decision taken in the previous iteration is also used for deciding the next position to be shifted 
by the swarm. But as iteration increases, the contribution of the previous decision is decreases 
and finally reaches zero in the final iteration. 
 
 
Fig 3.8 a PSO Iteration Cycle 
 
3.6 GA AND PSO APPLIED TO PROTEIN STRUCTURAL CLASS 
PREDICTION  
A protein can be represented by a 20-D unit vector through the following formulation. Suppose x 
is a protein to be predicted, and f i (x) (i = 1, 2, . . . , 20) represents the occurrence frequencies of 
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its 20 constituent amino acids. The compositions of the 20 amino acids in the protein x are given 
by the following normalization equation: 
 
 
Thus, in the composition space, the protein x can be expressed by the vector 
 
 
Because u1(x), u2 (x),. . . , u20 (x) are normalized as defined , the vector v(x) is a 20-D unit 
vector. Similarly, we can also use the following four standard unit vectors to represent the norms 
of the four protein structural classes: 
 
 
Where u 1(a), u 2(a)., . . , u20(a)  represent the average compositions of the 20 amino acids 
occurring in the 19 known a-type proteins, u1(P) , u2 ( p ) , . . . , u20 ( P ) the average 
compositions of the 20 amino acids occurring in the 15 known &type proteins, and so forth.  
 
Now initialize the GA parameters and run Genetic Algorithm to find out the structural classes in 
the protein. Below is the figure showing the GA process. 
 
 
 
 
 
 Finding structural classes in proteins using PSO algorithm. 
Starting particle positions and velocities were initialized at random. To reduce the problem of 
premature convergence to relative minima, the Attractive-Repulsive modification has been 
introduced. This modification defines a measure of global diversity (D) among the particles as: 
No of iteration=60 
No of chromosomes=10 
No of parameters to optimize=4 
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where S is the number of particles in the swarm, N is space dimension (the number of networks 
weights) and  is the average of the parameter j among the particles. 
 
If D falls below a minimal threshold (tmin) the update rule is inverted as follow 
 
 
 
causing the particles to spread in the phase space. If D reaches a maximal threshold (tmax) the 
update rule is restored as in the standard PSO method. We choose tmin = 0.1 and tmax = 5.0. 
The parameters c1, c2 and μ were set as in the original PSO method as c1 = c2 ∈ [0.0, 2.0] 
and μ = 0.7298. The maximum number of iterations was set to 10000. A population size of 5 
particles was chosen.  
 
3.7 SIMULATION RESULTS FOR PROTEIN STRUCTURAL CLASSES 
STUDY  
 
Table 3.2 Overall comparisons of results 
 
METHODS α β α + β α / β OVERALL 
EUCLIDEAN 
DISTANCE 
73% 82% 57%  49% 67% 
HAMMING 
DISTANCE 
71% 89% 57%  49% 68% 
PRINCIPAL 
COMPONENT 
ANALYSIS(PCA) 
82% 97% 78% 82% 85% 
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LOGIT-BOOST 90.4% 88.5% 73.9% 80% 83.8% 
SUPPORT VECTOR 
MACHINE(SVM) 
75% 90% 64% 64% 74.5% 
GENETIC 
ALGORITHM(GA) 
90% 94% 82% 80% 86.5% 
PARTICLE SWARM 
OPTIMIZATION(PSO) 
91% 94% 84% 80% 87.5% 
 
 
3.8 INFERENCE DRAWN FROM SIMULATION IN PROTEIN 
STRUCTURAL CLASS PREDICTION  
It can be seen from the simulation results that the prediction based on GA and PSO works very 
well and overall prediction also gives better results when compared to  Euclidean Distance, 
Hamming Distance , Principal Component Analysis(PCA) , Logit-boost and Support vector 
machine(SVM).  
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4.1INTRODUCTION 
Rapidly sequencing of genomic information of variety of organism have thrown considerable 
interest to both biology and computer science community. A major challenge for genomic 
research is to establish a relationship among sequences, structures and function of genes. In 
addition processing and analyzing this information are of prime importance. Basically genes are 
repositories for protein coding information and proteins in turn are responsible for most of the 
important biological functions in all cells. The traditional methods to analyze the genes in DNA 
based on the statistical and Discrete Fourier transform (DFT) are not robust, time consuming and 
unsuitable for future routine and rapid medical applications. In this chapter we propose a new 
method based on sliding DFT (SDFT) which is efficient and cost effective for DNA sequencing 
than the traditional Fourier Transform approach. In addition the DFT approach loses its 
effectiveness in case of small DNA sequences for which the autoregressive (AR) modeling has 
been used as an alternative tool. In this chapter we also propose an alternative but promising 
adaptive AR method for the same purpose and to improve the clarity of exon regions. Simulation 
study carried out on many DNA sequences subsequently reveals that a substantial savings in 
computation time is achieved by our methods without degrading the performance. 
 
4.2 SLIDING DFT 
The sliding DFT algorithm is an improved version of the traditional DFT process where the 
spectral bin output rate is equal to the input data rate on sample by sample basis with improved 
computational efficiency. The sliding DFT employs the idea of Goertzel algorithm and computes 
PROTEIN CODING REGION 
IDENTIFICATION 
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the DFT spectra through implementing an infinite impulse response (IIR) filter. The Z-transform 
function of the Goertzel filter is given by 
 
 
Where N is no. of samples of which the DFT is to be calculated. The sliding DFT (SDFT) 
algorithm performs an N-point DFT on time samples within a sliding window. The time window 
is then advanced by one or more samples and a new N-point DFT is calculated. The importance 
of this process is that each new DFT is efficiently computed directly from the result of the 
previous DFT. The principle used in the SDFT is the DFT shifting theorem or the circular shift 
property. It states that if the DFT of a windowed time domain sequence is X(k), then the DFT of 
that sequence, circularly shifted by one sample, is , where k is the DFT bin of 
interest. This process is expressed as 
 
 
Where x(n) is the new sample to be included in the windowed sequence, x(n-N) is the first 
sample of the sequence which is to be discarded and P(k); P(k-1) are the new and previous 
spectral components of the windowed time sequence respectively. This can be represented by an 
IIR filter and the Z-domain transform function of the sliding DFT filter is given by 
 
 
A better representation of the algorithm with correct phase and magnitude is given in 
 
 
The IIR filter implementation of SDFT is shown in Fig.4.1 
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Fig 4.1 An IIR implementation of the Sliding DFT 
 
4.3 AUTOREGRESSIVE MODELING 
The Fourier analysis based methods for detecting the protein coding regions in DNA lose their 
effectiveness in the case of small as well as standard DNA sequences. These methods are 
constrained by the frequency resolution and spectral leakage effects of the data record. Hence to 
overcome this problem model based approaches have been evolved which look the spectral 
analysis problem differently compared to Fourier Transform methods. The autoregressive (AR) 
model is one such method which has been proposed for detection for the 3-base periodicity in 
DNA sequence and to predict the protein coding regions. The AR modeling approach has been 
used successfully in speech processing and radar signal processing. It is a simple and robust 
method and requires no a priori knowledge of the sequence to be analyzed and also works well 
with low signal to noise (SNR) ratio. In AR modeling the observed signal x(n) can be modeled as 
a linear combination of its M past output values x(n - k) and present input u(n) as 
 
 
Where a(k) represents the coefficient of the model to be estimated. This AR process can be 
viewed as a recursive all pole digital filter whose transfer function is 
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In this case the number of filter coefficients is equal to the order of the model and is same as the 
number of filter poles which is to be determined efficiently. The Yule-Walker or Burg methods 
are usually used to determine these coefficients using the Levinson-Durbin recursive procedure. 
The spectral estimation for the AR model given as 
 
where σ2  is the variance of the input signal.  
 
4.4 NUMERICAL REPRESENTATION AND PRELIMINARY SPECTRAL 
MEASURE FOR CODING REGIONS 
 
To perform the gene prediction based on period-3 property the total DNA sequence is first 
converted into four indicator sequences, one for each base. The DNA sequence D(n) is mapped 
into binary signals uA(n); uC(n); uG(n) and uT (n),which indicate the presence or absence of 
these nucleotides at location n. For example the binary signal uA(n), attributed to nucleotide A 
takes a value of 1 at n = n0 if D(n0) = A, else uA(n0) is 0. 
Suppose the DNA sequence is represented as 
 
D(n) = [ATGATCGCAT] 
 
Then its numerical representation is given by 
 
uA(n)=[1 0 0 1 0 0 0 0 1 0] 
uC(n)=[0 0 0 0 0 1 0 1 0 0] 
uG(n)=[0 0 1 0 0 0 1 0 0 0] 
uT(n)=[0 1 0 0 1 0 0 0 0 1] 
 
uA (n)+ uC(n)+ uG(n)+ uT(n)=1   for n=0,1,2……….,N-1 
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4.5 MEASURE OF SPECTRAL CONTENT USING SDFT 
 
In this frequency domain method, the DFTs of the four binary indicator sequences are employed 
to exploit the 3-base periodicity. Let UA[k]; UG[k]; UC[k] and UT [k] represent the Discrete 
Fourier transform (DFT) of the corresponding binary sequences and is given by 
 
 
 
 
for x = A;C;G or T and k = 0; 1; 2; _ _ _ ;N - 1.Then the spectral content at k is given by 
 
 
S [k] = {UA[k]}
2
 + {UB[k]}
2
 + {UC[k]}
2
 + {UD[k]}
2
 
 
S[k]acts as a preliminary indicator of a coding region giving a peak at the 2π/3 frequency. This 
coding procedure can be used to detect the probable coding region in the DNA sequence. The 
progression of S[N/3] can be plotted by evaluating S[N/3] over a window of N samples, then 
sliding the window by one or more samples and recalculating S[N/3].This process is carried out 
over the entire DNA sequence. It is necessary that the window length N be sufficiently large 
(typical sizes are a few hundred eg 351 to a few thousand) so that the periodicity effect 
dominates the background noise spectrum. The conventional DFT method involves large 
computations which poses difficulty for online evolution of protein coding regions. The 
following section deals with the sliding DFT method, a fast approach in DSP literature for 
spectral estimation of the DNA sequences. 
 
Each of the four binary indicator sequences within the window is passed through this IIR filter 
and the corresponding DFT output sequence is obtained. The resulting DFTs are represented as 
PA[k]; PC[k]; PG[k] and PT [k]. Then the spectral content is computed as 
 
1
0
/2
N
n
Nknj
XX enukU
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S[k] =Σ [Px (k)]2 
where x stands for either of the sequences A, C, T or G. The successive progression of S[k] 
within the sliding window and the plot of S[N/3] exhibit the coding regions in DNA. Thus the 
SDFT requires only one complex multiplication and two real additions per output sample. Hence 
the computational complexity of each successive N-point output is O(N) for the sliding DFT 
compared to O(N
2
) for the DFT. As a result there is substantial computational saving in 
identifying the coding region by the proposed method. 
 
 
4.6 PROPOSED ADAPTIVE AR MODELING APPROACH 
 
For achieving online prediction of gene and exon the computational time needs to be reduced. 
Further the fixed AR method requires all data to be available simultaneously which is not always 
feasible. With a motive to alleviate these limitations an adaptive AR model based approach is 
suggested in this section for efficient prediction. The AR process can be viewed as an adaptive 
prediction error filter (all-zero filter) that adaptively adjusts its coefficients to flatten the 
spectrum of the signal to be observed. It is a fact that with a proper learning algorithm like LMS 
and RLS the weight vector of the adaptive prediction error filter converges to optimal AR 
coefficients. 
 
 
4.6.1 THE LMS PREDICTION ERROR FILTER 
A signal x(n) modeled as a M order AR process can be expressed as 
 
Where e(n) is the prediction error and W1; W2;……. ; Wm are AR coefficients. 
 
The LMS prediction error filter illustrated in Fig. 2 is used to adaptively estimate the optimal AR 
coefficients by minimizing the mean square value of prediction error. 
- 65 - 
 
 
Fig 4.2 LMS Prediction Error Filter 
The weight update equation of the filter is given by and μ is the step size that determines the rate 
of converge and stability of weights. 
The power spectra is estimated using the prediction error filter is given as 
 
 
where  is the variance of the prediction error signal. 
 
 
 
4.7 RESULTS 
 
 
Fig 4.3 Spectral plot of S[N/3] for gene F56F11.4a in the C-elegans chromosome III using DFT 
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Fig 4.4 Spectral plot of S[N/3] for gene F56F11.4a in the C-elegans chromosome III using SDFT 
 
 
Fig 4.5 Spectral plot of gene F56F11.4a in the C-elegans chromosome III using Fixed AR modeling 
 
 
 
Fig 4.6.Spectral plot of gene F56F11.4a in the C-elegans chromosome III using adaptive AR modeling 
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5.1 SCOPE FOR FUTURE WORK 
This kind of computational approach like Docking and QSAR will help us to extract the 
important descriptors from the existing drug series to add up a new molecule in the SARS 
Protease drug list and to combat with fast drug resistance property of the virus. Thus it can be 
inferred that the extracted descriptors and total negative binding energy play a major role in the 
maintenance of biological activity. Also the descriptors encoding significant structural 
information such as topological and constitutional environment can be used to get unique 
characteristics of compounds to build the relationship between the structure and biological 
activity. 
 
Owing to the fuzzy nature of the protein structural class definition and the possible experimental 
errors in protein data bank, the naive statistical mathematical methods might not work well for 
the protein structural class prediction. Application of evolutionary algorithms like BFO and 
improved GA can be applied to predict the structural class of proteins and coding regions more 
efficiently. 
 
 
 
 
 
 
 
 
SCOPE FOR FUTURE WORK  
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